文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

肝胰十二指肠切除术治疗胆管癌的价值与争议

[The value and controversy of hepatopancreatoduodenectomy in the treatment of cholangiocarcinoma].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2026-01-01

本文综述肝胰十二指肠切除术(HPD)在局部进展期胆管癌中的应用。HPD可提高切除率和R0切除率,但围手术期病死率与并发症发生率较高,生存获益仍存争议。目前HPD尚未成为常规治疗,需在严格适应证下于高手术量中心谨慎开展。

要点

  • HPD可用于同时累及肝门及胰周胆管的局部进展期胆管癌。
  • HPD提高切除率与R0率,但围手术期病死率和并发症发生率较高。
  • HPD生存获益存争议,尚未成为常规治疗,需严格适应证下谨慎开展。

核心结论

  • HPD可提高局部进展期胆管癌的切除率和R0切除率,但围手术期病死率和并发症发生率较高,生存获益仍存争议。
  • HPD尚未成为局部进展期胆管癌的常规治疗方式,需在严格把握适应证条件下于高手术量中心谨慎开展。

研究设计与样本

  • 本文为综述,汇总HPD在胆管癌中的适应证、术式策略、围手术期安全性及生存结局的最新研究进展。

主要发现

  • HPD针对同时累及肝门及胰周胆管的局部进展期胆管癌,可提高手术切除率和R0切除率。
  • HPD与较高的围手术期病死率和并发症发生率相关。
  • 近年来围手术期管理和手术技术进步使HPD安全性有所提高,部分患者可获得长期生存。

临床怎么用

  • HPD应在严格把握适应证的条件下、于高手术量中心谨慎开展。
  • 对局部进展期胆管癌,HPD可作为选定患者的根治性手术选项,但非标准治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cholangiocarcinoma is a highly aggressive malignancy with a poor prognosis, and surgical resection remains the only potentially curative treatment. Hepatopancreatoduodenectomy (HPD) represents a radical surgical option for selected patients with locally advanced cholangiocarcinoma involving both the perihilar region and the peripancreatic bile duct. Although HPD can increase the resection rate and the likelihood of achieving R0 margins, it is associated with substantial perioperative mortality and morbidity, and its survival benefit remains controversial. In recent years, advances in surgical techniques and perioperative management have improved the safety of HPD, allowing a subset of carefully selected patients to achieve long-term survival. However, HPD has not yet been established as a standard treatment for locally advanced cholangiocarcinoma and should be performed with caution under strict indications in high-volume centers. This review summarizes current evidence regarding the indications, surgical strategies, perioperative safety, and survival outcomes of HPD in the management of cholangiocarcinoma. 胆管癌是一种侵袭性强、预后较差的恶性肿瘤,手术切除是其唯一可能获得根治的手段。肝胰十二指肠切除术(HPD)是针对同时累及肝门及胰周胆管的局部进展期胆管癌可行的根治性选择。尽管该术式能够提高手术切除率和R0切除率,但其围手术期病死率和并发症发生率较高,生存获益仍存在争议。近年来,随着围手术期管理和手术技术的不断进步,HPD的安全性有所提高,部分患者可获得长期生存。然而,目前HPD尚未成为局部进展期胆管癌的常规治疗方式,其应用仍需在严格把握适应证的条件下,在高手术量中心谨慎开展。本文综述HPD在胆管癌中的适应证、术式策略、围手术期安全性及生存结局的最新研究进展。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang YH, Diao HR, Dong YS, et al. [The value and controversy of hepatopancreatoduodenectomy in the treatment of cholangiocarcinoma]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 41771518. doi:10.3760/cma.j.cn112139-20251102-00512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。